Atara Biotherapeutics
ATRA
ATRA
116 hedge funds and large institutions have $1.01B invested in Atara Biotherapeutics in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 52 increasing their positions, 23 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 120 → 116 (-4)
48% less capital invested
Capital invested by funds: $1.94B → $1.01B (-$928M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
116
Holding in Top 10
1
Calls
$4.18M
Puts
$1.56M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$14.4M | |
| 3 | +$12.5M | |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$12.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$7.33M |
Top Sellers
| 1 | -$38.3M | |
| 2 | -$29.9M | |
| 3 | -$11M | |
| 4 |
UONDDL
University of Notre Dame du Lac
South Bend,
Indiana
|
-$10.9M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$7.69M |